FIELD: medicine, tumor therapy. SUBSTANCE: method deals with elaborating monoclonal antibody conjugates with 14-bromide-4-dimetoxydaunorubicin. At the same time conjugate contains 2-8 molecules of medicine covalently connected with antibody or fragment and developing pharmaceutical composition that contains such a conjugate and also an acceptable diluent or carrier. EFFECT: higher specificity of medicine supply towards tumor. 3 cl, 3 tbl, 19 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARATION OF CYTOTOXIC CONJUGATION | 1988 |
|
RU2009500C1 |
| MONOCLONAL ANTIBODY PRODUCED BY THE STRAIN OF HYBRID CULTURED MURINE CELLS MUS MUSCULUS L | 1991 |
|
RU2073722C1 |
| ANTIBODIES SPECIFIC TO TUMOUR AND USE THEREOF | 2011 |
|
RU2595403C2 |
| NEUREGULIN ANTAGONISTS AND USE THEREOF IN TREATING MALIGNANT GROWTH | 2011 |
|
RU2587619C2 |
| THERAPEUTIC USE OF THE TLR AGONIST AND COMBINED THERAPY | 2011 |
|
RU2603467C2 |
| METHOD OF TREATMENT OF TUMORS | 2003 |
|
RU2323737C2 |
| FACTOR EFFECTING ON ACTIVITY OF TUMOR NECROSIS FACTOR RECEPTOR-RELEASING ENZYME | 1999 |
|
RU2279478C2 |
| ANTIBODIES AGAINST OX40 AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2562874C1 |
| ANTHRACYCLINE GLYCOSIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS SHOWING ANTITUMOR PROPERTIES, AND A METHOD OF THEIR SYNTHESIS | 1990 |
|
RU2043360C1 |
| PDGFRα ANTIBODIES FOR TREATING SECONDARY BONE TUMOUR | 2006 |
|
RU2502523C2 |
